Belmont, MA, United States of America

Simon Adam O'Neil


 

Average Co-Inventor Count = 12.1

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Simon Adam O'Neil

Introduction: Simon Adam O'Neil is a notable inventor based in Belmont, MA, with a strong background in pharmaceutical innovations. With three patents to his name, he has made significant contributions to the field, specifically regarding co-crystal formulations that enhance pharmaceutical compositions. His work continues to pave the way for advancements in drug formulations.

Latest Patents: One of Simon's latest patents focuses on "Co-crystals and pharmaceutical compositions comprising the same." This invention details compositions and co-crystals that comprise a compound with specific structural characteristics, involving co-crystal formers like adipic acid, citric acid, fumaric acid, maleic acid, succinic acid, or benzoic acid. The patent also encompasses innovative methods for creating and utilizing these compositions effectively.

Career Highlights: Simon currently works at Vertex Pharmaceuticals, Inc., a leading biotechnology company known for its commitment to developing transformative medicines for serious diseases. His role in this dynamic environment encourages continual innovation and collaboration, as he works to advance new therapeutic options through his research.

Collaborations: Throughout his career, Simon has collaborated with talented individuals such as Kwame Wiredu Nti-Addae and Michael Waldo. These partnerships have allowed for a rich exchange of ideas and expertise, further enhancing the innovative processes within his projects.

Conclusion: Simon Adam O'Neil exemplifies the spirit of innovation through his invaluable contributions to pharmaceutical sciences. With his ongoing work at Vertex Pharmaceuticals and a notable portfolio of patents, he continues to influence the field positively, driving forward novel solutions for improved therapeutic formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…